Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (721-730 of 839) with videos related to

Pageof 84
Sort By:
European Urology|March 23, 2011
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaborationDaher C Chade, Shahrokh F Shariat, Angel M Cronin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB DependenciesYi Liang, Sujeeve Jeganathan, Stefano Marastoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumorsDamien Faury, André Nantel, Sandra E Dunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy SpectrumLucia Nappi, Marisa Thi, Amy Lum, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2007
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentMeritxell Gironella, Mylène Seux, Min-Jue Xie, et al.
JSES International|February 7, 2022
The coronavirus disease clavicle study: a predictor of future trauma trendsGhazal Hodhody, Joann W Y Lum, Sadia Afzal, et al.
Molecular Cancer Research : MCR|January 27, 2022
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical ImplicationsXin Dong, Hui Xue, Fan Mo, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
The New England Journal of Medicine|October 22, 2025
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate CancerNeal D Shore, Murilo de Almeida Luz, Ugo De Giorgi, et al.
Pageof 84

Showing results (721-730 of 839) with videos related to

Sort By:
Pageof 84
European Urology|March 23, 2011
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaborationDaher C Chade, Shahrokh F Shariat, Angel M Cronin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB DependenciesYi Liang, Sujeeve Jeganathan, Stefano Marastoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumorsDamien Faury, André Nantel, Sandra E Dunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy SpectrumLucia Nappi, Marisa Thi, Amy Lum, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2007
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentMeritxell Gironella, Mylène Seux, Min-Jue Xie, et al.
JSES International|February 7, 2022
The coronavirus disease clavicle study: a predictor of future trauma trendsGhazal Hodhody, Joann W Y Lum, Sadia Afzal, et al.
Molecular Cancer Research : MCR|January 27, 2022
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical ImplicationsXin Dong, Hui Xue, Fan Mo, et al.
Journal of Medicinal Chemistry|October 18, 2021
Development of 2-(5,6,7-Trifluoro-1<i>H</i>-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate CancerEric Leblanc, Fuqiang Ban, Ayse Derya Cavga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
The New England Journal of Medicine|October 22, 2025
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate CancerNeal D Shore, Murilo de Almeida Luz, Ugo De Giorgi, et al.
Pageof 84